Centrus Energy Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, executive compensation, and key governance proposals. All items except the officer exculpation amendment passed. Shareholder engagement and procedural transparency were emphasized, with no proposal-related questions received.
-
Q1 2026 saw strong operational progress, a $900M HALEU award, and raised revenue guidance to $450–$500M. Segment results showed higher technical solutions revenue and improved gross margin, with $1.9B in cash supporting expansion and strategic partnerships.
Fiscal Year 2025
-
2025 saw record revenue, strong backlog growth, and a $900M HALEU award, positioning for domestic uranium enrichment and national security. 2026 guidance is flat, with major investments in capacity and workforce, and a focus on de-risking supply and execution.
-
Q3 2025 revenue rose 30% year-over-year to $74.9 million, with net income of $3.9 million and a $3.9 billion backlog. Major capital raises, new hiring, and strong market demand position the company for rapid expansion amid tight enrichment supply and rising SWU prices.
-
Q2 2025 saw strong gross margins and robust cash reserves despite lower revenue, with significant progress in HALEU production and a growing backlog. The company is well-positioned for future growth, pending DOE funding decisions and continued industry momentum.
-
Q1 2025 saw strong revenue and profit growth, driven by shipment timing and improved margins, with a robust cash position and significant backlog. The company remains the only U.S.-owned uranium enricher, is expanding capacity, and awaits DOE funding decisions amid strong political support.
Fiscal Year 2024
-
Revenue grew 40% year-over-year to $442 million, with strong margin performance and a $3.7 billion backlog. Major DOE contract wins, a $60 million manufacturing investment, and $402.5 million in convertible notes position the company for growth amid rising uranium prices and U.S. policy shifts.
-
Q3 2024 saw $57.7M in revenue and a $5M net loss, with results in line with expectations amid normal contract timing variability. Major new DOE awards and $2B in customer commitments support future growth, while backlog reached $3.8B.
-
Q2 2024 saw revenue of $189 million and net income of $30.6 million, with strong LEU deliveries and a strengthened balance sheet. Pension obligations were reduced by 90%, and the company is well positioned for growth amid supportive U.S. policy and industry demand.
-
Nuclear sector momentum is rising due to energy independence and carbon-free goals, with enrichment remaining a highly restricted, high-barrier segment. The company is uniquely positioned as the only U.S. HALEU producer, with strong growth prospects in advanced reactors and national security.